Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Operating Expenses | 1,496 | 1,586 | 1,471 | 1,304 | 1,384 |
| Operating Income | -1,496 | -1,586 | -1,471 | -1,304 | -1,384 |
| Interest Expense | 9 | 0 | 61 | 0 | 0 |
| Other Income | 473 | 799 | -519 | 432 | 218 |
| Pre-tax Income | -1,032 | -788 | -2,051 | -872 | -1,166 |
| Income Tax | 39 | 97 | 43 | 37 | 202 |
| Net Income Continuous | -1,072 | -885 | -2,094 | -908 | -1,368 |
| Net Income | $-1,072 | $-885 | $-2,094 | $-908 | $-1,368 |
| EPS Basic Total Ops | -95.50 | 30.00 | -236.00 | -112.00 | -360.00 |
| EPS Basic Continuous Ops | -95.51 | 29.59 | -235.27 | -111.68 | -360.66 |
| EPS Diluted Total Ops | -95.50 | 30.00 | -236.00 | -112.00 | -360.00 |
| EPS Diluted Continuous Ops | -95.51 | 29.59 | -235.27 | -111.68 | -360.66 |
| EPS Diluted Before Non-Recurring Items | -96.00 | -44.00 | -236.00 | N/A | N/A |
| EBITDA(a) | $-1,493 | $-1,584 | $-1,468 | $-1,300 | $-1,381 |